课题基金基金详情
Akkermansia muciniphila诱导视黄酸分泌调控ILC3/IL-22轴 促进溃疡性结肠炎黏膜愈合的机制研究
结题报告
批准号:
81970465
项目类别:
面上项目
资助金额:
55.0 万元
负责人:
智发朝
依托单位:
学科分类:
消化道内环境紊乱、黏膜屏障障碍及相关疾病
结题年份:
2023
批准年份:
2019
项目状态:
已结题
项目参与者:
智发朝
国基评审专家1V1指导 中标率高出同行96.8%
结合最新热点,提供专业选题建议
深度指导申报书撰写,确保创新可行
指导项目中标800+,快速提高中标率
客服二维码
微信扫码咨询
中文摘要
肠道共生菌与固有淋巴细胞ILC3间的相互作用不仅影响溃疡性结肠炎(UC)的发生发展,还在UC黏膜愈合中发挥重要作用。树突状细胞(DC)分泌的视黄酸(RA)是肠道共生菌调控ILC3/IL-22通路的重要分子,但共生菌是否依赖RA促进黏膜修复仍未阐明。前期我们发现Akkermansia muciniphila(A. muciniphila)促进小鼠实验性肠炎黏膜修复,且上调肠道ILC3比例和DC中RA关键酶RALDH2表达。我们推测A. muciniphila通过上调DC中RA表达,进而激活ILC3/IL-22通路,介导肠上皮增殖修复,最终促进UC肠黏膜愈合。本项目拟构建小鼠肠炎模型,结合临床样本、转基因动物和体外实验,深入探讨共生菌与免疫细胞间互作进而影响肠黏膜愈合的调控模式和作用机制。本项目将为共生菌促进UC黏膜愈合提供新理论依据及A. muciniphila防治UC的临床应用奠定基础。
英文摘要
The interaction between intestinal commensal bacteria and type 3 innate lymphoid cells (ILC3s) determines the progression of ulcerative colitis (UC) and plays an important role in mucosal healing. Retinoic acid (RA) secreted by dendritic cells holds an important position in ILC3/IL-22 axis meditated by the gut commensals. However, whether there is any relationship between the therapitic effect of gut commensals and beneficial effect of RA remains unclear. In our previous research, we found that Akkermansia muciniphila (A. muciniphila) can promote the mucosal healing in mouse colitis model induced by DSS and increase intestinal ILC3 percentage and RALDH2 expression in lamina propria dendritic cells, which is a key synthase of RA. We hypothesized that A. muciniphila may exert its therapeutic function by upregulating the expression of RA in dendritic cells, which contributes to the proliferation and healing of gut mucosa by up-regulating ILC3/IL-22 axis. In this project, we plan to construct the mouse model of UC combined with clinical samples, transgenic animals and in vitro experiments, to unveil the regulation pattern and mechanism by which the process of intestinal mucosal healing is affected by the interaction between symbiotic bacteria and intestinal immune cells. This research will provide a fresh theoretical basis for symbiotic bacteria-mediated UC mucosal healing, and prepare for the clinical application of A. muciniphila in the treatment of UC.
期刊论文列表
专著列表
科研奖励列表
会议论文列表
专利列表
DOI:10.1186/s12916-022-02352-x
发表时间:2022-04-15
期刊:BMC MEDICINE
影响因子:9.3
作者:Huang, Chongyang;Wang, Jun;Liu, Hongbin;Huang, Ruo;Yan, Xinwen;Song, Mengyao;Tan, Gao;Zhi, Fachao
通讯作者:Zhi, Fachao
Safety Evaluation and Probiotic Potency Screening of Akkermansia muciniphila Strains Isolated from Human Feces and Breast Milk.
从人类粪便和母乳中分离的阿克曼氏菌菌株的安全性评价和益生菌效力筛选
DOI:10.1128/spectrum.03361-22
发表时间:2023-02-14
期刊:Microbiology spectrum
影响因子:3.7
作者:
通讯作者:
DOI:10.3389/fnut.2022.1063699
发表时间:2022
期刊:FRONTIERS IN NUTRITION
影响因子:5
作者:Zhou, Qian;Shen, Binhai;Huang, Ruo;Liu, Hongbin;Zhang, Wendi;Song, Mengyao;Liu, Ke;Lin, Xinlong;Chen, Shuze;Liu, Yangyang;Wang, Ye;Zhi, Fachao
通讯作者:Zhi, Fachao
DOI:10.3389/fimmu.2023.1156762
发表时间:2023
期刊:Frontiers in immunology
影响因子:7.3
作者:
通讯作者:
DOI:10.1186/s40168-023-01546-6
发表时间:2023-05-02
期刊:Microbiome
影响因子:15.5
作者:
通讯作者:
Akkermansia muciniphila下调DUOX2/ROS/STAT3轴介导的增殖信号抑制结肠炎相关性结肠癌的机制研究
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    55万元
  • 批准年份:
    2021
  • 负责人:
    智发朝
  • 依托单位:
脆弱拟杆菌上调ILC3/IL-22/pSTAT3通路促进炎症性肠病黏膜愈合的机制研究
  • 批准号:
    81770530
  • 项目类别:
    面上项目
  • 资助金额:
    54.0万元
  • 批准年份:
    2017
  • 负责人:
    智发朝
  • 依托单位:
Cdc42对炎症性肠病中Th17细胞和潘氏细胞作用的研究
  • 批准号:
    81370502
  • 项目类别:
    面上项目
  • 资助金额:
    70.0万元
  • 批准年份:
    2013
  • 负责人:
    智发朝
  • 依托单位:
MAWBP通过MAPK-NF-κB通路在溃疡性结肠炎EMT中的作用及分子机制研究
  • 批准号:
    81170341
  • 项目类别:
    面上项目
  • 资助金额:
    45.0万元
  • 批准年份:
    2011
  • 负责人:
    智发朝
  • 依托单位:
国内基金
海外基金